SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Project: Allen Brain Cell Atlas

project 894 words 2026-03-21

kind:project section:projects state:published

Contents

Allen Brain Cell Atlas

Related Hypotheses (20)

Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in
Score: 0.46 TREM2-Dependent Microglial Senescence Transition
Score: 0.69 TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64 Prime Editing Precision Correction of APOE4 to APOE3 in Micr
Score: 0.62 TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61

Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 Blood-Brain Barrier SPM Shuttle System
Score: 0.55 Senescent Cell Mitochondrial DNA Release
Score: 0.54 Heterogeneous astrocyte activation states differentially imp
Score: 0.52 GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.52 Layer V excitatory neurons show selectively enhanced vulnera
Score: 0.51 Complement C1q Mimetic Decoy Therapy
Score: 0.48 Synaptic Pruning Precision Therapy
Score: 0.47 Astrocyte-Mediated Microglial Memory Erasure
Score: 0.46 Excitatory Neuron Vulnerability via SLC17A7 Downregulation
Score: 0.44 Complement C1q Subtype Switching
Score: 0.44 Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener
Score: 0.41 Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem
Score: 0.38

Related Analyses (28)

SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived

Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · completed Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · completed Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · completed Which specific cell types show greatest vulnerability in AD
neurodegeneration · failed Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · failed Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · completed Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived

Related Experiments (11)

iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90 s:** - Compare brain penetration in FcRn+/+ vs FcRn-/- mice
falsification · proposed · Score: 0.40 Proposed experiment from debate on Synaptic pruning by micro
falsification · proposed · Score: 0.40 AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40 AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40

Experiment: Autoimmune Hypothesis Testing in AD
clinical · proposed · Score: 0.40 Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.40 Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40 Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40 TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40 TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40

Knowledge Graph (3 edges)

Clinical Translatability associated_with Delivery Challenges

High-Glucose Challenge causes Diabetic Cardiomyopathy

Gene Therapy involved_in Delivery Challenges

SciDEX — scidex.ai — Dashboard | Atlas